Literature DB >> 24573940

P50 auditory sensory gating in first onset schizophrenics and normal healthy adults.

Hongxing Wang1, Mingdao Zhang, Xingshi Chen, Feiying Lou, Jianhua Liang, Chong Chen, Tiantao Shi, Qiulin Lu.   

Abstract

The aim of this research was to investigate the variations of P50 auditory sensory gating (P50) in normal healthy adults and the first onset schizophrenics. By using the American Nicolet Bravo electromyography/evoked potential (EMG/EP) system, P50 was measured with conditioning-testing paradigm (paired-click stimuli S1 and S2 were used) in 58 first onset schizophrenics and 108 healthy adults, and the Positive and Negative Syndrome Scale (PANSS) was applied. The following three conclusions have been reached. (1) In normal control (NC) group, measured from central, anterior and posterior zone (Cz, Fz and Pz respectively), there were no statistical differences (P > 0.05) between S1 and S2 evoked P50 peak latencies (S1-P50 and S2-P50); the amplitudes of S2-P50 [(2.2 ± 1.4), (2.3 ± 1.5) and (2.1 ± 1.4) μV respectively] reduced significantly as compared with S1-P50 [(5.6 ± 3.3), (5.6 ± 3.9) and (4.9 ± 2.8) μV respectively] (P < 0.01); the S2/S1 ration, S1-S2 difference, and 100 (1-S2/S1) had no statistical differences (P > 0.05). (2) Compared with NC, the schizophrenic group significantly showed lower S1-P50 amplitudes (P < 0.01, except at Pz in which Z = 2.030, P = 0.042), higher S2-P50 amplitudes, higher S2/S1 ratio, lower S1-S2 difference, and more decreased 100 (1-S2/S1) (P < 0.01) at Cz, Fz and Pz. (3) No significant correlations were found among S2/S1 ratio, S1-S2, 100 (1-S2/S1) of sensory gating and PANSS (P > 0.05) in schizophrenic group. The first onset schizophrenics had sensory gating deficits, which could be quantified by P50.

Entities:  

Year:  2007        PMID: 24573940     DOI: 10.1007/s11684-007-0084-5

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  9 in total

Review 1.  Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients?

Authors:  G A Light; D L Braff
Journal:  Biol Psychiatry       Date:  2000-03-01       Impact factor: 13.382

2.  Guidelines for using human event-related potentials to study cognition: recording standards and publication criteria.

Authors:  T W Picton; S Bentin; P Berg; E Donchin; S A Hillyard; R Johnson; G A Miller; W Ritter; D S Ruchkin; M D Rugg; M J Taylor
Journal:  Psychophysiology       Date:  2000-03       Impact factor: 4.016

3.  Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating.

Authors:  N N Boutros; A Belger
Journal:  Biol Psychiatry       Date:  1999-04-01       Impact factor: 13.382

Review 4.  Elementary phenotypes in the neurobiological and genetic study of schizophrenia.

Authors:  L E Adler; R Freedman; R G Ross; A Olincy; M C Waldo
Journal:  Biol Psychiatry       Date:  1999-07-01       Impact factor: 13.382

5.  Gender differences in gating of the auditory evoked potential in normal subjects.

Authors:  W P Hetrick; C A Sandman; W E Bunney; Y Jin; S G Potkin; M H White
Journal:  Biol Psychiatry       Date:  1996-01-01       Impact factor: 13.382

6.  Improved p50 auditory gating with ondansetron in medicated schizophrenia patients.

Authors:  Lawrence E Adler; Ellen M Cawthra; Kara A Donovan; Josette G Harris; Herbert T Nagamoto; Ann Olincy; Merilyne C Waldo
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

7.  P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study.

Authors:  B Oranje; B N van Berckel; C Kemner; J M van Ree; R S Kahn; M N Verbaten
Journal:  Biol Psychiatry       Date:  1999-04-01       Impact factor: 13.382

8.  Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

Authors:  N C Andreasen; S Arndt; V Swayze; T Cizadlo; M Flaum; D O'Leary; J C Ehrhardt; W T Yuh
Journal:  Science       Date:  1994-10-14       Impact factor: 47.728

9.  Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.

Authors:  Lawrence E Adler; Ann Olincy; Ellen M Cawthra; Kara A McRae; Josette G Harris; Herbert T Nagamoto; Merilyne C Waldo; Mei-Hua Hall; Amanda Bowles; Laurie Woodward; Randal G Ross; Robert Freedman
Journal:  Am J Psychiatry       Date:  2004-10       Impact factor: 18.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.